Domov › Rak jajčnikov › Distrikta Columbia › Washington
Klinične študije za Rak jajčnikov v Washington, DC
23 študij za Rak jajčnikov išče udeležence na lokacijah v Washington in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
The Vanguard Study: Testing a New Way to Screen for Cancer
Vključevanje udeležencevVabljeni zdravi prostovoljci
- Walter Reed National Military Medical Center, Bethesda · 7 mi stran
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Vključevanje udeležencevFaza 2
- Walter Reed National Military Medical Center, Bethesda · 7 mi stran
- National Institutes of Health Clinical Center, Bethesda · 7 mi stran
Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies
Vključevanje udeležencevFaza 1
- National Institutes of Health Clinical Center, Bethesda · 7 mi stran
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
Vključevanje udeležencevFaza 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi stran
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
Vključevanje udeležencevOpazovalna študija
- National Institutes of Health Clinical Center, Bethesda · 7 mi stran
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
Vključevanje udeležencevOpazovalna študija
- National Institutes of Health Clinical Center, Bethesda · 7 mi stran
Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
Vključevanje udeležencevFaza 1
- National Institutes of Health Clinical Center, Bethesda · 7 mi stran
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Vključevanje udeležencevFaza 2
- Holy Cross Hospital /ID# 275872, Silver Spring · 7 mi stran
Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
Vključevanje udeležencevFaza 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi stran
A Study of Raludotatug Deruxtecan With or Without Bevacizumab as First-Line Maintenance Treatment in Non-HRD-Positive Advanced Ovarian Cancer (MK-5909-006, (ENGOT-ov102/GOG-3141/ REJOICE-Ovarian 04)
Vključevanje udeležencevFaza 3
- MedStar Washington Hospital Center ( Site 0026), Washington D.C.
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Vključevanje udeležencevFaza 1
- Georgetown University Medical Center, Washington D.C.
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Vključevanje udeležencevFaza 3
- Holy Cross Hospital, Silver Spring · 7 mi stran
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Vključevanje udeležencevFaza 2
- Medstar Georgetown University Hospital, Washington D.C.
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
Vključevanje udeležencevFaza 3
- Holy Cross Hospital, Silver Spring · 7 mi stran
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Vključevanje udeležencevFaza 1/2
- Children's National Medical Center, Washington D.C.
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
Vključevanje udeležencevFaza 1
- Normunity Investigational Site, Washington D.C.
Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
Vključevanje udeležencevFaza 1/2
- National Institutes of Health Clinical Center, Bethesda · 7 mi stran
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
Vključevanje udeležencevFaza 2
- USA11-0, Bethesda · 7 mi stran
18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
Vključevanje udeležencevFaza 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi stran
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- Cancer Support Community Research & Training Institute, Washington D.C.
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Vključevanje udeležencevOpazovalna študija
- Massive Bio SYNERGY-AI site, Silver Spring · 7 mi stran
- Massive Bio SYNERGY-AI site, Bethesda · 7 mi stran
CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing
Vključevanje udeležencevVabljeni zdravi prostovoljci
- Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
BP1001-A in Patients With Advanced or Recurrent Solid Tumors
Vključevanje udeležencevFaza 1
- Holy Cross Hospital, Silver Spring · 7 mi stran
Študije za Rak jajčnikov v drugih mestih
- Houston, TX89 študij
- New York City, NY69 študij
- Boston, MA61 študij
- Los Angeles, CA50 študij
- Nashville, TN49 študij
- Arlington, VA46 študij
- Philadelphia, PA44 študij
- Columbus, OH39 študij
- St. Louis, MO38 študij
- Chicago, IL36 študij
- San Antonio, TX31 študij
- Cleveland, OH30 študij
Druge študije v Washington
- Rak (vse vrste)58 študij
- Nemalicelični pljučni rak55 študij
- Rak dojke46 študij
- Metastatski rak43 študij
- Rak pljuč41 študij
- Rak prostate38 študij
- Debelost33 študij
- Kolorektalni rak29 študij
- Srčno-žilne bolezni28 študij
- Rak mehurja26 študij
- Akutna mieločna levkemija24 študij
- Limfom23 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.